21 CFR Part 211

Streamline compliance with 21 CFR Part 211 using Kallik’s powerful labeling and artwork management solutions. Our innovative software simplifies the complex requirements of pharmaceutical and biologic labeling, helping manufacturers achieve accuracy, consistency, and full regulatory compliance.

With advanced automation, version control, and approval workflows, Kallik’s software ensures each label meets FDA standards while reducing costly errors and speeding up your time to market. Maintain complete traceability, improve quality control, and confidently grow your business in the regulated pharmaceutical industry with Kallik’s trusted solution.

What is 21 CFR Part 211?

21 CFR Part 211 is a key regulation issued by the U.S. Food and Drug Administration (FDA) governing current Good Manufacturing Practices (cGMP) for finished pharmaceuticals. It ensures that pharmaceutical products are produced consistently and meet quality standards for their intended use, focusing on aspects such as production, packaging, labeling, and holding of drugs.

Pharmaceutical

21 CFR Part 211 directly impacts manufacturers of prescription and over-the-counter drugs, as well as biologics. These companies must implement stringent quality control processes, covering everything from production to labeling and distribution. Requirements for detailed documentation and record-keeping ensure traceability, while quality assurance testing helps verify batch consistency and stability. Labeling requirements mandate accuracy in dosage, patient instructions, and safety warnings to prevent harmful errors, emphasizing the need for advanced labeling and artwork management systems.

Medical Devices

Medical device companies producing combination products, such as drug-eluting stents, insulin pens, or pre-filled syringes, must comply with pharmaceutical-level regulations for the drug component of their devices. This necessitates robust clinical testing, quality control measures, and adherence to labeling regulations outlined in 21 CFR Part 211. Combination product labeling must include clear, compliant information about the device and drug components, ensuring patient safety and regulatory adherence. Maintaining documentation for audits is critical, as regulators require proof to quality management and consistency across the product lifecycle.

How Does 21 CFR Part 211 Impact Labeling and Artwork Management

Compliance with 21 CFR Part 211 significantly impacts labeling and artwork management by enforcing strict requirements for label clarity, accuracy, and regulatory adherence. Companies must exercise meticulous control over labeling processes, documenting each step, from artwork creation to final application. Key details, such as product identification, dosage instructions, usage warnings, and expiration dates, must be closely monitored to avoid costly errors. Even minor mislabeling issues can result in fines, recalls, or legal consequences, making adherence to these regulations essential.

In response, companies are increasingly adopting advanced labeling and artwork management systems that ensure end-to-end oversight, track artwork changes, manage approvals, and maintain version control to prevent unauthorized modifications. Automation and AI-driven solutions reduce human error, improve accuracy, and expedite compliant updates across global markets. Additionally, 21 CFR Part 211 emphasizes batch and lot traceability, requiring detailed records of every label revision. Modern software solutions help maintain this audit trail, supporting swift action in the event of a recall and providing ongoing compliance. Through these systems, companies can enhance patient safety, protect their brand reputation, and meet regulatory standards efficiently.

How Veraciti Can Help

Veraciti ensures full compliance with 21 CFR Part 211 by providing a centralized platform for managing all aspects of labeling and artwork. Our software offers version control, real-time collaboration, and automated approval workflows, reducing the risk of human error. Veraciti’s audit trails and focus on regulations enables businesses to stay compliant by maintaining detailed records of all changes and updates made to product labeling, ensuring accuracy and traceability throughout the process.

Making 21 CFR Part 211 Compliance Simple with Veraciti

Kallik has a wealth of experience working with life sciences organizations and manufacturers. Our label and artwork management solution, Veraciti™ is continuously adapting to the changing requirements of the pharmaceutical industry. Get in touch today and see how Kallik can benefit your labeling and artwork management process.

Book a demo